Metagenomi Inc. Common St... (MGX)
undefined
undefined%
At close: undefined
3.32
0.15%
After-hours Dec 13, 2024, 07:52 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21
Net Income -68.25M -43.59M -21.44M
Depreciation & Amortization 4.21M 1.73M 387.00K
Stock-Based Compensation 6.92M 1.96M 375.00K
Other Working Capital -23.89M 65.66M 44.23M
Other Non-Cash Items -7.85M 1.08M 1.24M
Deferred Income Tax - - -
Change in Working Capital -26.43M 69.49M 46.26M
Operating Cash Flow -91.41M 29.72M 24.26M
Capital Expenditures -9.81M -13.98M -2.90M
Acquisitions - - -
Purchase of Investments -208.10M -214.85M -71.41M
Sales Maturities Of Investments 263.64M 106.63M -
Other Investing Acitivies - -108.22M -71.41M
Investing Cash Flow 45.73M -122.20M -74.32M
Debt Repayment - - 29.97M
Common Stock Repurchased - - -
Dividend Paid - - -
Other Financial Acitivies 1.01M 239.59M 9.95M
Financial Cash Flow 1.01M 239.59M 39.92M
Net Cash Flow -44.66M 147.12M -10.14M
Free Cash Flow -101.22M 15.75M 21.35M